Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2006 (Vol. 26, No. 2)

FAS Biological and Chemical Weapons Control

  • Broad coverage
  • Needs more frequent updating
A couple of years ago, concerns about biological and chemical weapons seemed to be greater than it is today. I'm not sure why the focus has changed. May be it is because the tremendous attention the media has paid recently to natural biological hazards, such as the spread of the avian flu and the outbreaks of polio in places as close as Minnesota, has stolen the spotlight. The FAS Biological and Chemical Weapons Control site however, is focused on these topics. Its stated aim is to raise the awareness of scientists to these issues. It does so by keeping abreast of relevant legislation, technological developments, news, and resources. It's not a total solution however, as news reports are spotty at best, and the site as a whole needs more frequent updating.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »